Stock listing

KRX:008930 Hanmi Science Co., Ltd (한미사이언스) 주가

Follow Hanmi Science Co., Ltd into a list and get an email when it puts out news.

Share price · KRX:008930

₩51,700 KRW -700 (-1.3%)

Close on Nov 20, 2026

Past year +33.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩50,200 – ₩54,300 KRWNov 20, 2026
Volume
167,897 sharesNov 20, 2026
Market cap
₩3.50T KRWAt the close on Nov 20, 2026 · price × 67.75M shares outstanding
52-week range
₩25,600 – ₩63,800 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩19.24B KRWMedian day 240,734 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Hanmi Science Co., Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:008930 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩51,700-700-1.3%₩50,900₩54,300₩50,200167,897
₩52,400-2,000-3.7%₩53,300₩54,800₩51,400116,255
₩54,400+1,400+2.6%₩53,500₩54,800₩52,500127,238
₩53,000+1,400+2.7%₩51,700₩54,100₩51,500152,467
₩51,600-3,200-5.8%₩52,300₩53,500₩50,800271,681
₩54,800-1,000-1.8%₩53,200₩54,800₩50,700337,947
₩55,800-1,400-2.4%₩57,300₩60,400₩54,400452,548
₩57,200-100-0.2%₩56,900₩59,600₩56,600197,489
₩57,300+3,000+5.5%₩54,400₩58,500₩54,400309,663
₩54,300+1,700+3.2%₩49,300₩55,500₩48,600467,727
₩52,600+3,600+7.3%₩50,000₩53,300₩49,950368,292
₩49,000+4,550+10.2%₩44,450₩49,200₩44,200312,326
₩44,450+950+2.2%₩43,700₩46,150₩42,850207,326
₩43,500+400+0.9%₩42,050₩44,850₩42,050164,635
₩43,100+900+2.1%₩43,000₩43,350₩40,050314,105
₩42,200+750+1.8%₩42,100₩42,650₩40,200249,230
₩41,450+50+0.1%₩41,500₩45,350₩41,250269,190
₩41,400-850-2.0%₩42,050₩42,750₩41,300113,040
₩42,250+650+1.6%₩40,700₩43,250₩40,700114,214
₩41,600-1,300-3.0%₩42,400₩42,450₩40,350179,588
₩42,900-700-1.6%₩42,950₩44,850₩42,700150,721
₩43,600-450-1.0%₩44,450₩45,800₩43,150156,643
₩44,050-1,500-3.3%₩45,200₩46,850₩42,500208,018
₩45,550-2,150-4.5%₩45,000₩46,650₩40,250465,339
₩47,700+2,250+5.0%₩44,450₩49,500₩44,150258,930
₩45,450+1,300+2.9%₩42,800₩45,850₩41,800360,655
₩44,150-6,050-12.1%₩49,000₩49,300₩43,400402,084
₩50,200-1,400-2.7%₩49,650₩52,700₩49,450231,297
₩51,600-3,300-6.0%₩52,100₩53,800₩49,400379,438
₩54,900-3,200-5.5%₩63,200₩63,800₩51,7001,181,941
₩58,100+500+0.9%₩57,800₩58,800₩56,400702,637
₩57,600+2,300+4.2%₩55,000₩57,700₩54,200189,368
₩55,300+2,600+4.9%₩52,600₩55,700₩51,000162,367
₩52,700-100-0.2%₩52,500₩54,400₩51,800120,931
₩52,800+600+1.1%₩52,500₩53,700₩51,100126,865
₩52,200-200-0.4%₩52,100₩53,000₩50,00080,128
₩52,400+300+0.6%₩52,500₩53,500₩51,300103,889
₩52,100+1,400+2.8%₩51,000₩53,400₩51,000126,640
₩50,700-100-0.2%₩50,900₩51,200₩49,95083,261
₩50,800+2,300+4.7%₩48,550₩51,300₩48,500105,247
₩48,500-2,400-4.7%₩50,900₩51,300₩48,300576,323
₩50,900-200-0.4%₩51,500₩52,700₩50,600134,288
₩51,100-500-1.0%₩51,300₩52,000₩49,400155,024
₩51,600+1,900+3.8%₩49,250₩52,900₩49,250213,772
₩49,700-600-1.2%₩49,100₩50,600₩47,950250,377
₩50,300-4,800-8.7%₩52,400₩55,300₩50,000285,080
₩55,100-900-1.6%₩55,000₩56,300₩51,400497,443
₩56,000-1,700-2.9%₩57,200₩57,900₩55,400270,110
₩57,700+3,500+6.5%₩54,400₩61,000₩53,300818,252
₩54,200+1,400+2.7%₩52,500₩54,600₩49,950423,833
₩52,800+1,300+2.5%₩51,900₩54,400₩51,450320,035
₩51,500+3,700+7.7%₩48,450₩54,000₩47,700780,062
₩47,800+2,000+4.4%₩44,700₩48,750₩44,600413,719
₩45,800+1,000+2.2%₩44,800₩46,050₩44,600188,373
₩44,800+300+0.7%₩43,500₩45,100₩42,900196,400
₩44,500+2,400+5.7%₩42,250₩44,650₩41,900232,237
₩42,100-2,300-5.2%₩43,300₩45,150₩41,800441,518
₩44,400-1,900-4.1%₩46,500₩47,450₩44,300703,278
₩46,300-10,200-18.1%₩52,500₩52,500₩45,0501,455,867
₩56,500+11,550+25.7%₩45,550₩57,500₩45,4004,107,170
₩44,950+700+1.6%₩43,350₩45,600₩43,000175,368
₩44,250-900-2.0%₩45,700₩45,900₩43,500161,063

Splits

8 splits since 2009 · KRX:008930 · every price before a split is adjusted for it

DayRatioWhat
51-for-50Split
51-for-50Split
21-for-20Split
21-for-20Split
5-for-1Split
21-for-20Split
1-for-4Consolidation
21-for-20Split
Ticker
KRX:008930
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Hanmi Science Co., Ltd news

Hanmi Science Co., Ltd on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
1 in the last 12 months · 2 in all · newest Jan 28, 2026 · oldest 2025

Valuation

P/E 23.2× against a median of 18.5×: 7th lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩3.40T KRW
P/E
23.2×
EV/sales
2.5×
EV/EBITDA
57.2×
Price/book
3.3×
Gross margin
61.8%
Operating margin
3.6%
Net margin
10.8%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Hanmi Science Co., Ltd · KRX:008930US$2.60BUS$2.53B23.2×2.5×57.2×3.3×10.8%0.0×n/a
China Medical System Holdings Ltd. · HKEX:867US$2.87BUS$2.13B12.8×1.7×7.7×1.1×18.1%0.1×n/a
Joincare Pharmaceutical Group Industry Co., Ltd. Class A · SSE:600380US$2.80BUS$1.16B16.5×0.6×n/a1.3×8.4%0.1×n/a
Livzon Pharmaceutical Group, Inc. Class A · SZSE:000513US$2.72BUS$1.65B11.7×1.1×n/a1.4×15.2%0.0×n/a
Bavarian Nordic A/S · OMXCOP:BAVAUS$2.70BUS$2.38B20.5×2.6×8.6×1.4×14.2%0.0×n/a
Betta Pharmaceuticals Co., Ltd. Class A · SZSE:300558US$2.64BUS$2.72B66.1×4.8×n/a2.7×7.0%0.2×n/a
Hybio Pharmaceutical Co., Ltd. Class A · SZSE:300199US$2.60BUS$2.71B43.1×11.8×n/a16.1×26.3%0.9×n/a
Hypera S.A. · BMFBOVESPA:HYPE3US$2.58BUS$3.55B8.5×2.3×7.4×1.0×20.1%0.5×n/a
Kangmei Pharmaceutical Co., Ltd Class A · SSE:600518US$2.57BUS$2.37B189×3.3×n/a2.3×1.9%0.0×n/a
Granules India Limited · NSE:GRANULESUS$2.42BUS$2.32B31.4×3.6×16.1×3.4×12.1%0.2×n/a
Prestige Consumer Healthcare Inc. · NYSE:PBHUS$2.35BUS$4.39B15.2×3.8×13.4×1.2×13.3%1.1×0.34
Median of the othersUS$2.62BUS$2.37B18.5×2.9×8.6×1.4×13.8%0.1×0.34

Events

QuarterResultsShare move
Q1 2026Apr 23, 2026 · Before open+0.4%
Q3 2025Oct 29, 2025 · Before open−3.0%
Q2 2025Jul 28, 2025 · Before open−7.5%
Q1 2025Apr 25, 2025 · Before open+0.3%
Q4 2024Feb 6, 2025 · Before open+1.1%
Q3 2024Oct 31, 2024 · After close−24.1%
Q2 2024Jul 30, 2024 · After close−3.1%
Q1 2024May 3, 2024 · After close+2.2%
Q4 2023Feb 2, 2024 · After close−3.1%
Q3 2023Nov 1, 2023 · After close+1.2%
All 20 quarters
QuarterResultsShare move
Q2 2023Jul 28, 2023 · After close−1.7%
Q1 2023Apr 26, 2023 · After close−1.9%
Q4 2022Feb 8, 2023 · After close+2.5%
Q3 2022Nov 1, 2022 · After close+1.7%
Q2 2022Jul 26, 2022 · Before open−0.3%
Q1 2022Apr 27, 2022 · Before open+3.4%
Q3 2021Nov 4, 2021+0.3%
Quarter to Jun 30, 2021Jul 29, 2021−2.6%
Quarter to Mar 31, 2021Apr 27, 2021−2.2%
Quarter to Dec 31, 2020Feb 4, 2021−2.9%

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.36T1.28T1.25T1.05T950.2B857.4B816.6B708.0B652.3B665.3B
Cost of revenue1.04T1.01T982.8B884.0B817.4B736.7B708.3B615.6B562.2B581.7B
Gross profit315.5B272.6B265.1B162.1B132.8B120.7B108.3B92.4B652.3B665.3B
Selling, general and administrative138.6B127.2B106.4B70.8B52.7B47.5B44.9B39.2B598.4B615.5B
Operating income57.0B38.0B57.0B28.1B28.8B25.2B16.1B11.0B14.0B15.1B
Depreciation and amortization9.48B9.71B8.73B5.48B5.26B6.21B6.37B4.61B4.68B3.20B
EBITDA66.4B47.7B65.7B33.6B34.0B31.4B22.5B15.6B18.7B18.3B
Interest expense10.6B11.3B10.2B3.69B1.79B1.70B1.73B1.10B00
Income before tax133.0B63.1B130.5B73.2B49.1B30.0B35.4B18.8B33.4B18.9B
Income tax6.18B7.37B4.69B798.3M2.58B11.0B
Net income118.4B59.4B115.1B69.2B42.9B22.6B30.7B18.0B30.1B7.94B
Earnings per share, basic1,748.09877.541,693.401,038.20638.33349.47475.27278.54464.73

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents127.4B85.2B27.6B21.4B16.6B14.8B16.7B26.9B38.4B102.5B
Short-term investments783.6M4.02B6.93B92.8M38.5M177.7M364.0M5.49B
Receivables104.4B102.1B106.9B98.8B93.5B86.6B91.1B101.4B107.5B127.3B
Inventory122.5B108.7B104.9B112.2B106.0B110.2B100.9B102.8B107.7B95.7B
Current assets425.8B328.0B273.9B245.3B222.6B215.7B217.1B244.5B261.3B330.0B
Property, plant and equipment26.0B25.6B26.3B25.7B27.1B27.7B
Total assets1.49T1.35T1.23T1.11T949.9B923.2B910.8B916.5B938.8B969.2B
Accounts payable116.7B111.8B59.8B77.6B104.6B123.9B130.9B153.6B176.9B197.4B
Current liabilities483.5B468.8B395.2B347.7B221.0B220.1B228.2B227.2B244.6B304.7B
Long-term debt350.0M10.2B5.82B5.00B
Total liabilities529.9B510.4B438.7B384.9B259.6B264.5B265.1B263.5B273.6B321.7B
Shareholders' equity961.9B840.9B787.5B724.7B690.3B658.7B645.7B653.1B665.2B645.3B
Shares outstanding67.7M67.7M68.0M66.7M67.3M64.7M64.7M64.7M64.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations47.7B83.0B35.2B9.45B13.7B13.8B13.0B2.70B-33.7B76.5B
Capital spending-20.9B-11.6B-8.68B-8.34B-1.82B-958.4M-1.25B-769.6M-2.21B-6.03B
Free cash flow26.7B71.3B26.5B1.11B11.5B11.9B11.1B1.52B-37.8B70.5B
Cash from investing-2.15B-6.78B-32.5B3.89B-23.0B-23.7B
Cash from financing-11.0B-9.01B9.06B-18.2B-6.11B-44.9B
Dividends paid-13.5B-20.3B-13.3B-13.2B-12.9B-12.7B-12.4B-12.2B-12.2B-27.6B
Share buybacks-1.93B-7.83B-622.6M-1.01B-348.3M-647.3M-998.1M-834.5M-1.77B
Change in cash42.2B57.6B6.16B4.83B1.74B-1.90B-10.1B-11.5B-64.2B8.15B

Open Financials

Cap table

Built by 6ix from Hanmi Science Co., Ltd’s releases

Common shares
67,751,141
Fully diluted
67,751,141

Fully diluted

LineShares
Common shares67,751,141

Share count over time

CountShares
Nov 22, 202667,751,141

Open Cap table

Shareholders

Funds

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund280KUS$6.96MNo changeJul 31, 2026
iShares Core MSCI Emerging Markets ETF234KUS$4.93M+4,113May 31, 2026
Vanguard Developed Markets Index Fund184KUS$3.61MNo changeJun 30, 2026
Schwab International Equity ETF49,240US$1.04M+1,352May 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund43,092US$1.07MNo changeJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF42,771US$832K−40Jun 30, 2026
Emerging Markets Core Equity 2 Portfolio35,933US$892KNo changeJul 31, 2026
Vanguard Pacific Stock Index Fund22,067US$548KNo changeJul 31, 2026
WisdomTree Emerging Markets SmallCap Dividend Fund19,859US$386K−216Jun 30, 2026
Dimensional Emerging Markets Value Fund19,539US$485KNewJul 31, 2026
All 35 holders
HolderSharesValueChangeAs of
Dimensional Emerging Markets Core Equity 2 ETF17,264US$434KNo changeJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account16,712US$328KNo changeJun 30, 2026
Franklin FTSE South Korea ETF14,688US$286K+8,988Jun 30, 2026
Vanguard Total World Stock Index Fund12,822US$318KNo changeJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF11,875US$299K+3,124Jul 31, 2026
Avantis Emerging Markets Equity ETF10,244US$216KNo changeMay 31, 2026
Dimensional Emerging Core Equity Market ETF8,621US$217KNo changeJul 31, 2026
The Emerging Markets Small Cap Series8,191US$203KNewJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio6,614US$129KNo changeJun 30, 2026
Dimensional Emerging Markets Value ETF6,483US$163KNewJul 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF4,650US$97,962−728May 31, 2026
Emerging Markets ex China Core Equity Portfolio3,745US$92,938+2,608Jul 31, 2026
World ex U.S. Core Equity Portfolio3,354US$83,234+1,269Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio3,018US$74,894−1,188Jul 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF2,133US$53,635No changeJul 31, 2026
Avantis Emerging Markets Small Cap Equity ETF1,970US$41,502No changeMay 31, 2026
Avantis Emerging Markets Equity Fund1,621US$34,150No changeMay 31, 2026
Dimensional World ex U.S. Sustainability Targeted Value Portfolio1,182US$29,337NewJul 31, 2026
World ex U.S. Targeted Value Portfolio1,014US$25,167NewJul 31, 2026
Dimensional Emerging Markets ex China Core Equity ETF932US$23,436−15Jul 31, 2026
Avantis Emerging Markets ex-China Equity ETF807US$17,001+3May 31, 2026
State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF807US$15,705+86Jun 30, 2026
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund552US$13,880No changeJul 31, 2026
Destinations International Equity Fund157US$3,302No changeMay 31, 2026
Franklin FTSE Asia ex Japan ETF84US$1,635No changeJun 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Hanmi Science Co., Ltd.